{"id":"W4220721699","doi":"10.1002/cam4.4635","title":"A <scp>WIN</scp> Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Waterloo Institute for Nanotechnology, University of Waterloo; University of California, San Diego; Fondation ARC pour la Recherche sur le Cancer; Pfizer","keywords":"Axitinib; Medicine; Avelumab; Palbociclib; Internal medicine; Oncology; Neutropenia; Lung cancer; Pembrolizumab; Cancer; Adverse effect; Gastroenterology; Immunotherapy; Chemotherapy; Breast cancer; Sunitinib; Metastatic breast cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005750222,0.0005542085,0.001212063,0.0004503583,0.0002960307,0.00001357977,0.0002827276,0.00006870525,0.001005782],"category_scores_gemma":[0.0001621004,0.0005168735,0.00008323766,0.0009728717,0.0002916699,0.0002354536,0.0002631269,0.00100537,0.000002854188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009765635,"about_ca_system_score_gemma":0.0005683642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060202,"about_ca_topic_score_gemma":0.0003830723,"domain_scores_codex":[0.9962634,0.0001517202,0.00085649,0.001050486,0.0007642244,0.0009137218],"domain_scores_gemma":[0.9980317,0.0003383686,0.0003672835,0.0006311314,0.0001708947,0.0004605771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003241778,0.003469476,0.6275522,0.001779185,0.0007770605,0.00214605,0.1165399,0.002303779,0.06855245,0.0000581526,0.003699781,0.1698802],"study_design_scores_gemma":[0.2307845,0.01087739,0.2620382,0.003631472,0.002079568,0.0003431388,0.260333,0.004112643,0.01328831,0.0001651091,0.2110512,0.001295408],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9584659,0.03471703,0.0001427711,0.001435455,0.001463926,0.002562937,0.00009066978,0.0001540594,0.0009672023],"genre_scores_gemma":[0.9842051,0.002342854,0.0001842619,0.002148203,0.0008883132,0.007132583,0.0000344506,0.0001491992,0.002915014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.365514,"threshold_uncertainty_score":0.9999074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04458647732105899,"score_gpt":0.344888726281933,"score_spread":0.300302248960874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}